OCA at 10:51, 22 May 2024

OCA — Wed, 22 May 2024 10:51:59 GMT

←Older revision		Revision as of 10:51, 22 May 2024
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 8pz6 is ~~ON HOLD until Paper~~ Publication	+	==crystal structure of VDR in complex with D-Bishomo-1a,25-dihydroxyvitamin D3 analog 56==
		+	<StructureSection load='8pz6' size='340' side='right'caption='[[8pz6]], [[Resolution\|resolution]] 2.90Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[8pz6]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Danio_rerio Danio rerio] and [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8PZ6 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8PZ6 FirstGlance]. <br>
		+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.9Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=IG5:(1~{R},3~{R})-5-[(2~{E})-2-[(4~{a}~{R},5~{S},9~{a}~{S})-4~{a}-methyl-5-[(2~{R})-6-methyl-6-oxidanyl-heptan-2-yl]-3,4,5,6,7,8,9,9~{a}-octahydro-2~{H}-benzo[7]annulen-1-ylidene]ethylidene]-2-(3-oxidanylpropylidene)cyclohexane-1,3-diol'>IG5</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8pz6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8pz6 OCA], [https://pdbe.org/8pz6 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8pz6 RCSB], [https://www.ebi.ac.uk/pdbsum/8pz6 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8pz6 ProSAT]</span></td></tr>
		+	</table>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/VDRA_DANRE VDRA_DANRE] Nuclear hormone receptor. Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes. Regulates transcription of hormone sensitive genes via its association with the WINAC complex, a chromatin-remodeling complex. Plays a central role in calcium homeostasis.<ref>PMID:17218092</ref>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	The biologically active metabolite of vitamin D(3) - calcitriol - is a hormone involved in the regulation of calcium-phosphate homeostasis, immunological processes and cell differentiation, being therefore essential for the proper functioning of the human body. This suggests many applications of this steroid in the treatment of diseases such as rickets, psoriasis and some cancers. Unfortunately, using therapeutic doses of calcitriol is associated with high concentrations of this compound which causes hypercalcemia. For this reason, new calcitriol analogs are constantly sought, devoid of calcemic effects but maintaining its beneficial properties. In this study, we present the synthesis of vitamin D derivatives characterized by an enlarged (seven-membered) ring D. Preparation of the designed vitamin D compounds required separate syntheses of crucial building blocks (C/D-rings fragments with side chain and rings A) which were combined by different methods, including Wittig-Horner reaction and Suzuki coupling. Biological activities of the target vitamin D analogs were assessed both in vitro and in vivo, demonstrating their significant potency compared to the natural hormone. Furthermore, the successful crystallization of these compounds with the vitamin D receptor (VDR) enabled us to investigate additional molecular interactions with this protein.

-	~~Authors~~:	+	Design, synthesis, and biological activity of D-bishomo-1alpha,25-dihydroxyvitamin D(3) analogs and their crystal structures with the vitamin D nuclear receptor.,Fabisiak A, Brzeminski P, Sicinski RR, Rochel N, Maj E, Filip-Psurska B, Wietrzyk J, Plum LA, DeLuca HF Eur J Med Chem. 2024 May 5;271:116403. doi: 10.1016/j.ejmech.2024.116403. Epub , 2024 Apr 10. PMID:38615411<ref>PMID:38615411</ref>

-	~~Description~~:	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	[[Category: ~~Unreleased~~ Structures]]	+	</div>
		+	<div class="pdbe-citations 8pz6" style="background-color:#fffaf0;"></div>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Danio rerio]]
		+	[[Category: Homo sapiens]]
		+	[[Category: Large Structures]]
		+	[[Category: Rochel N]]

OCA at 04:05, 9 August 2023

OCA — Wed, 09 Aug 2023 04:05:29 GMT

←Older revision		Revision as of 04:05, 9 August 2023
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 8pz6 is ON HOLD	+	The entry 8pz6 is ON HOLD until Paper Publication

	Authors:		Authors:

OCA: Protected "8pz6" [edit=sysop:move=sysop]

OCA — Wed, 02 Aug 2023 09:15:16 GMT

Protected "8pz6" [edit=sysop:move=sysop]

←Older revision

Revision as of 09:15, 2 August 2023

OCA: New page: '''Unreleased structure''' The entry 8pz6 is ON HOLD Authors: Description: Category: Unreleased Structures

OCA — Wed, 02 Aug 2023 09:15:13 GMT

New page: '''Unreleased structure''' The entry 8pz6 is ON HOLD Authors: Description: Category: Unreleased Structures

New page

'''Unreleased structure'''

The entry 8pz6 is ON HOLD

Authors:

Description:
[[Category: Unreleased Structures]]

8pz6 - Revision history

OCA at 10:51, 22 May 2024

OCA at 04:05, 9 August 2023

OCA: Protected "8pz6" [edit=sysop:move=sysop]

OCA: New page: '''Unreleased structure''' The entry 8pz6 is ON HOLD Authors: Description: Category: Unreleased Structures